| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |